MedTrace Logo

Intestinal Biomarker Analysis After ECP for ICI Colitis

NCT06074874 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-04-03

No results posted yet for this study

Summary

It was previously shown that ICI-colitis can be treated with extracorporeal photophoresis. Therefore this retrospective analysis is launched to study the chnages of immune cells in the peripheral blood and intestinal tract in an ICI colitis patient cohort. The analysis will include the evaluation of intestinal and peripheral blood biomarkers in patients with ICI colitis receiving ECP as a treatment.

Conditions

  • Colitis
  • Immune Checkpoint Inhibitor-Related Colitis

Interventions

OTHER

Intestinal tissue analysis

Intestinal tissue analysis

Sponsors & Collaborators

  • University of Freiburg

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-03-30
Completion
2024-03-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06074874 on ClinicalTrials.gov